Martin Taylor-Rowan

Martin Taylor-Rowan is a Research Fellow at the University of Glasgow's College of Medical, Veterinary & Life Sciences, School of Medicine, Dentistry & Nursing. His primary affiliation is with the Evidence Synthesis Group at the Complex Reviews Support Unit (CRSU), where he conducts research focused on stroke outcomes, cognitive decline, and geriatric assessment tools.

Dr. Taylor-Rowan's research interests center on the intersection of stroke medicine and cognitive aging. His work investigates how physical and brain frailty impact stroke outcomes, develops patient-reported measures for treatment burden assessment after stroke (including the PETS-Stroke instrument), and examines anticholinergic burden as a risk factor for cognitive decline. He makes significant contributions to systematic review methodology and European Stroke Organisation guidelines.

His publication record shows a strong focus on high-impact systematic reviews and clinical guidelines, with recent work emphasizing patient-centered outcome measures in stroke rehabilitation. Dr. Taylor-Rowan frequently collaborates with Professor Terence J. Quinn and contributes to major multicenter studies examining delirium, frailty, and cognitive outcomes in older stroke patients.

Dr. Taylor-Rowan currently holds active research funding through the National Institute for Health and Care Research (NIHR153934) from 2023-2028, supporting his work in evidence synthesis for stroke and geriatric medicine. His research program involves multiple international collaborations and contributes directly to clinical guideline development through the European Stroke Organisation.

His work with the Evidence Synthesis Group at CRSU positions him at the forefront of methodological innovation in evidence-based stroke medicine, with particular emphasis on translating research findings into practical clinical tools for assessing treatment burden and cognitive outcomes in stroke survivors.